Dr. Liu's areas of clinical interest include living donor liver transplantation, outcomes of liver transplantation, complications of cirrhosis, and chronic hepatitis B infection and the porphyrias.
Dr. Liu earned his B.S. in Biology at the University of the Philippines and an M.D. at the University of the East Ramon Magsaysay Memorial Medical Center. He completed his internship and residency training in Internal Medicine at St. Luke's-Roosevelt Hospital Center and fellowships in gastroenterology and general/transplant hepatology at St. Luke's-Roosevelt Hospital Center and The Mount Sinai Medical Center, respectively. Prior to his return to Mount Sinai this year as an attending, Dr. Liu had been the Assistant Training Director at both the Department of Medicine and the Division of Gastroenterology at Cebu Doctors' University Hospital (Philippines).
Dr. Liu is fluent in Hokkien, Tagalog, and Cebuano.
MD, University of the East
Internship, Internal Medicine
St. Lukes Roosevelt Hospital
Residency, Internal Medicine
St. Lukes Roosevelt Hospital
St. Lukes Roosevelt Hospital
Mount Sinai Hospital
Chinese (Other), English, Filipino, Tagalog (Philippines)
Liu LU, Qin L, Knisely AS. A patient with persistent pruritus. Seminars in liver disease 2010 May; 30(2).
Liu L MD, Schiano T MD. Hepatotoxicity of herbal medicines, vitamins and natural hepatotoxins. In: Informa Healthcare USA, Inc; pp733-754.
Liu LU, Schiano TD. Long-term care of the liver transplant recipient. Clinics in liver disease 2007 May; 11(2).
Liu LU, Schiano TD. Hepatitis C immune globulin (human) for the prevention of viral recurrence after liver transplantation. Expert review of clinical immunology 2007 Mar; 3(2).
Liu LU, Schiano TD. Adult Live Donor Liver Transplantation. Clin Liver Dis. 2005 Nov; 9(4): 767-86.
Liu LU, Bodian CA, Gondolesi GE, Schwartz ME, Emre S, Roayaie S, Schiano TD. Marked differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation 2005; 80: 1072-1080.
Liu LU, Haddadin HA, Bodian CA, Sigal SH, Korman JD, Bodenheimer HC Jr, Schiano TD. Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest 2004 Jul; 126(1): 142-8.
Liu LU, Schiano TD, Lau N, O'Rourke M, Min AD, Sigal SH, Drooker M, Bodenheimer HC Jr. Survival and recidivism risk in methadone-dependent patients undergoing liver transplantation. Am J Transplant 2003 Oct; 3(10): 1273-7.
Liu LU, Schiano TD, Min AD, Kim-Schluger L, Schwartz ME, Emre S, Fishbein TM, Bodenheimer HC Jr, Miller CM. Syngeneic living-donor liver transplantation without the use of immunosuppression. Gastroenterology 2002 Oct; 123(4): 1341-5.
Liu LU, Abittan CS, Schiano TD, Jaffe DL, Fishbein TM. Endoscopic diagnosis of bleeding Meckel's diverticulum in a multivisceral transplant recipient. Am J Transplant 2003 Jan; 3(1): 82-4.
Singal AK, Parker C, Bowden C, Thapar M, Liu L, McGuire BM. Liver transplantation in the management of porphyria. Hepatology (Baltimore, Md.) 2014 Sep; 60(3).
Yasuda M, Erwin AL, Liu LU, Balwani M, Chen B, Kadirvel S, Gan L, Fiel MI, Gordon RE, Yu C, Clavero S, Arvelakis A, Naik H, Martin LD, Phillips JD, Anderson KE, Sadagoparamanujam VM, Florman SS, Desnick RJ. Liver Transplantation for Acute Intermittent Porphyria: Biochemical and Pathologic Studies of the Explanted Liver. Molecular medicine (Cambridge, Mass.) 2015; 21.
Liu L, Phillips J, Bonkovsky H. Porphyria Cutanea Tarda, Type II.. In: Porphyrias Consortium of the Rare Diseases Clinical Research Network. GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2013.;.
Liu L, Phillips J, HB. Clinical Research Network. Hepatoerythropoietic Porphyria. In: Porphyrias Consortium of the Rare Diseases . GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2013;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Liu did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.